Skip to main content Accessibility help
×
Home
  • Print publication year: 2019
  • Online publication date: December 2018

Chapter 1 - Basic Principles in Clinical Neuroendocrinology I: Receptor Mechanisms

Barton, M. (2016). Not lost in translation: emerging clinical importance of the G protein-coupled estrogen receptor GPER. Steroids 111, 3745.
Ben-Shlomo, A & Melmed, S. (2010). Pituitary somatostatin receptor signaling. Trends Endocr Metab 21, 123133.
Bernard, V, Young, J, Chanson, P & Binart, N. (2015). New insights in prolactin: pathological implications. Nat Rev Endocr 11, 265275.
Brooks, A J & Waters, M J. (2010). The growth hormone receptor: mechanism of activation and clinical implications. Nat Rev Endocr 6, 515525.
Chaidarun, S S, Swearingen, B & Alexander, JM. (1998). Differential expression of estrogen receptor-β (ERβ) in human pituitary tumors: functional interactions with ERα and a tumor-specific splice variant. J Clin Endocr Metab 83, 33083315.
Charmandari, E, Kino, T, Ichijo, T & Chrousos, G P. (2008). Generalized glucocorticoid resistance: clinical aspects, molecular mechanisms, and implications of a rare genetic disorder. J Clin Endocr Metab 93, 15631572.
Charmandari, E, Kino, T & Chrousos, G P. (2013). Primary generalized familial and sporadic glucocorticoid resistance (Chrousos syndrome) and hypersensitivity. Endocr Dev 24, 6785.
Dodington, D W, Desai, H R & Woo, M. (2018). JAK/STAT – Emerging players in metabolism. Trends Endocr Metab 29, 5565.
Engel, J B & Schally, A V. (2007). Drug insight: clinical use of agonists and antagonists of luteinizing-hormone-releasing hormone. Nat Clin Practice Endocr Metab 3, 157167.
Farooqi, IS, Wangensteen, T, Collins, S et al. (2007). Clinical and molecular genetic spectrum of congenital deficiency of the leptin receptor. New Engl J Med 356, 237247.
Fukami, M, Suzuki, E, Igarashi, M, Miyado, M & Ogata, T. (2018). Gain-of-function mutations in G-protein–coupled receptor genes associated with human endocrine disorders. Clin Endocr 88, 351359.
Hauser, A S, Attwood, M M, Rask-Andersen, M, Schiöth, H B & Gloriam, D E. (2017). Trends in GPCR drug discovery: new agents, targets and indications. Nat Revs Drug Discovery 16, 829842.
Hiort, O. (2013). Clinical and molecular aspects of androgen insensitivity. Endocr Develop 24, 3340.
Huang, D, Yang, F, Wang, Y & Guan, X. (2017). Mechanisms of resistance to selective estrogen receptor down-regulator in metastatic breast cancer. Biochim Biophys Acta 1868, 148156.
Hwa, V. (2016). STAT5B deficiency: impacts on human growth and immunity. Growth Horm IGF Res 28, 1620.
Jayasena, C N, Nijher, G M K, Chaudhri, O B et al. (2009). Subcutaneous injection of kisspeptin-54 acutely stimulates gonadotropin secretion in women with hypothalamic amenorrhea, but chronic administration causes tachyphylaxis. J Clin Endocr Metab 94, 43154323.
Jia, M, Dahlman-Wright, K & Gustafsson, J A. (2015). Estrogen receptor alpha and beta in health and disease. Best Prac Res Clin Endocr Metab 29, 557568.
Lania, A G, Mantovani, G & Spada, A. (2006). Mechanisms of disease: mutations of G proteins and G-protein-coupled receptors in endocrine diseases. Nat Clin Practice Endocr Metab 2, 681693.
Manoranjan, B, Salehi, F, Scheithauer, B W, Rotondo, F, Kovacs, K & Cusimano, M D. (2010). Estrogen receptors alpha and beta immunohistochemical expression: clinicopathological correlations in pituitary adenomas. Anticancer Res 30, 28972904.
McEwan, I J & Brinkmann, A O. (2016). Androgen physiology: Receptor and metabolic disorders. In: Endocrinology of Male Reproduction; Simoni, M & Huhtaniemi, I T, Eds. Berlin: Springer. www.Endotext.org.
Monteleone, P, Mascagni, G, Giannini, A, Genazzani, A R & Simoncini, T. (2018). Symptoms of menopause – global prevalence, physiology and implications. Nat Rev Endocr 14, 199215.
Myers Jr., M G, Leibel, R L, Seeley, R J & Schwartz, M W. (2010). Obesity and leptin resistance: distinguishing cause from effect. Trends Endocr Metab 21, 643651.
Neumann, E, Khawaja, K & Müller-Ladner, U. (2014). G protein-coupled receptors in rheumatology. Nat Rev Rheumatol 10, 429436.
Ortiga-Carvalho, T M, Sidhaye, A R & Wondisford, F E. (2014). Thyroid hormone receptors and resistance to thyroid hormone disorders. Nat Rev Endocr 10, 582591.
Paterni, I, Granchi, C, Katzenellenbogen, J A & Minutolo, F. (2014). Estrogen receptors alpha (ERα) and beta (ERβ): subtype-selective ligands and clinical potential. Steroids 90, 1329.
Prossnitz, ER & Barton, M. (2011). The G-protein-coupled estrogen receptor GPER in health and disease. Nat Rev Endocr 7, 715726.
Rodriguez, J M, Monsalves-Alvarez, M, Henriquez, S, Llanos, M N & Troncoso, R. (2016). Glucocorticoid resistance in chronic diseases. Steroids 115, 182192.
Rosenfeld, R G, Belgorosky, A, Camacho-Hubner, C, Savage, M O, Wit, J M & Hwa, V. (2007). Defects in growth hormone receptor signaling. Trends Endocr Metab 18, 134140.
Simmen, R C M & Kelley, A S. (2016). Reversal of fortune: estrogen receptor-beta in endometriosis. J Mol Endocr 57, F23F27.
Southworth, M B, Matsumoto, A M, Gross, K M, Soules, M R & Bremner, W J. (1991). The importance of signal pattern in the transmission of endocrine information: pituitary gonadotropin responses to continuous and pulsatile gonadotropin-releasing hormone. J Clin Endocr Metab 72, 12861289.
Vandewalle, J, Luypaert, A, De Bosscher, K & Libert, C. (2018). Therapeutic mechanisms of glucocorticoids. Trends Endocr Metab 29, 4254.
Vassart, G & Costagliola, S. (2011). G protein-coupled receptors: mutations and endocrine diseases. Nat Rev Endocr 7, 362372.
Warner, M, Huang, B & Gustafsson, J-A. (2017). Estrogen receptor β as a pharmaceutical target. Trends Pharmacol Sci 38, 9299.
Wettschureck, N & and Offermanns, S. (2005). Mammalian G proteins and their cell type specific functions. Physiol Rev 85, 11591204.